CalciMedica annual free cash flow
2019
2020
2021
2022
2023
2024
2025
CalciMedica Free Cash Flow (FCF) History (CALC)
CalciMedica reported −$21.2M in free cash flow for fiscal 2025, a decrease of $52,000 from the previous fiscal year.
View full CalciMedica company overviewCalciMedica free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$21.2M | −$52,000 | — | — |
| 2024 | 2024-12-31 | −$21.2M | $4.7M | — | — |
| 2023 | 2023-12-31 | −$25.8M | −$14.0M | — | — |
| 2022 | 2022-12-31 | −$11.8M | $20.2M | — | — |
| 2021 | 2021-12-31 | −$32.0M | $1.1M | — | — |
| 2020 | 2020-12-31 | −$33.1M | −$1.3M | — | — |
| 2019 | 2019-12-31 | −$31.8M | — | — | — |
CalciMedica quarterly free cash flow
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$4.6M | $2.1M | — | — |
| Q1 2026 | 2026-03-31 | −$4.9M | $31,000 | — | — |
| Q4 2025 | 2025-12-31 | −$4.9M | $116,000 | — | — |
| Q3 2025 | 2025-09-30 | −$4.8M | −$113,000 | — | — |
| Q2 2025 | 2025-06-30 | −$6.7M | $117,000 | — | — |
| Q1 2025 | 2025-03-31 | −$4.9M | −$172,000 | — | — |
| Q4 2024 | 2024-12-31 | −$5.0M | −$403,000 | — | — |
| Q3 2024 | 2024-09-30 | −$4.7M | −$584,000 | — | — |
| Q2 2024 | 2024-06-30 | −$6.8M | −$5.0M | — | — |
| Q1 2024 | 2024-03-31 | −$4.7M | −$2.5M | — | — |
| Q3 2023 | 2023-09-30 | −$4.6M | −$941,000 | — | — |
| Q4 2022 | 2022-12-31 | −$4.1M | $4.9M | — | — |
| Q3 2022 | 2022-09-30 | −$1.8M | $3.9M | — | — |
| Q2 2022 | 2022-06-30 | −$2.2M | $5.7M | — | — |
| Q1 2022 | 2022-03-31 | −$3.6M | $5.8M | — | — |
| Q4 2021 | 2021-12-31 | −$9.0M | $1.6M | — | — |
| Q3 2021 | 2021-09-30 | −$5.7M | −$277,000 | — | — |
| Q2 2021 | 2021-06-30 | −$7.9M | −$1.7M | — | — |
| Q1 2021 | 2021-03-31 | −$9.4M | $1.5M | — | — |
| Q4 2020 | 2020-12-31 | −$10.6M | — | — | — |
| Q3 2020 | 2020-09-30 | −$5.4M | — | — | — |
| Q2 2020 | 2020-06-30 | −$6.2M | — | — | — |
| Q1 2020 | 2020-03-31 | −$10.9M | — | — | — |
CalciMedica free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$33.1M to −$21.2M, a net increase of $11.9M. CalciMedica's latest reported quarter, Q2 2026, generated −$4.6M in free cash flow, an increase of $2.1M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review CalciMedica filings at SEC.gov ↗